Application Note

Ensure The Safety And Purity Of Your Cell Therapy Product With Mycoplasma And Sterility Testing

By Mike Brewer and Sharon Rouw

GettyImages-1439447135-stem-cell-dna

See the latest innovations in mycoplasma and sterility testing for biopharma. This new application note illustrates how these streamlined workflows and rapid turnarounds can increase efficiency and support faster delivery of life-saving therapeutics to patients. Discover how the Applied Biosystems™ MycoSEQ™ Plus system and Applied Biosystems™ SteriSEQ™ Rapid Sterility Testing System can help accelerate your cell therapy manufacturing process.

access the Application Note!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Thermo Fisher Scientific Bioproduction